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Response to Dawe
We thank Dawe for his interest and comments on our paper.
He makes two points: that previous studies have shown
site-to-site variation in ultraviolet sensitivity (and that our
study confirms this data), and the second questions wheth-
er our criticisms of the minimal erythema dose (MED) are
merely ‘‘rhetorical’’.
He is correct in that previous studies have, as we cited,
shown variation in erythemal responses between some dif-
ferent body sites. But, no previous study has systematically
attempted to partition and contrast variation within persons
with that between persons using appropriate statistical and
experimental methodology. Prior to the advent of appropri-
ate quantification of erythemal reactions by Diffey, Farr, and
others in the 1980s (Diffey et al, 1984; Farr and Diffey, 1984),
assessments relied on visual inspection of erythema, a
method that is inadequate for the task at hand.
Our criticisms of the MED are of course not rhetorical
(see the accompanying commentary by Bickers, 2004). The
MED, like the Fitzpatrick phototype classification, is an in-
appropriate measure for use in experimental medicine—and
we suspect clinical medicine (Rees, 2002). We are of course
not the first to point this out (Farr and Diffey, 1984). It is a
threshold measure, different researchers define it differently,
it fails to take account of the different dose–response gra-
dients in different people (Flanagan et al, 2001), and is con-
founded by surrounding pigmentation. Phrases such as
‘‘50% of MED’’ have no coherency as the gradients of ery-
themal dose responses vary between people and with site.
More importantly, it presupposes a misleadingly simplistic
relation between erythema, subjective discomfort, efficacy,
and photoadaptation. The continued acceptance of it owes
more to tradition, the inherent broad therapeutic safety ratio
of ultraviolet radiation, and the dead weight of clinical
guidelines. It is with relief that those practitioners who ad-
minister ionizing radiation use slightly more sophisticated
quantitative tools: we urge our colleagues to do likewise.
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